2021
SJR Q2
JCR Q3 · 2,3
36 matched articles
Journal detail
Journal of the American Society of Hypertension
- Publisher
- Elsevier Ireland Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
19331711
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,642
- Quartile Q2
- H-Index 63
- Cites/doc 0
- Docs (3y) 122
- Cites (3y) 304
Clarivate
Web of Science · JCR · 2018
- JCR Q Q3
- JIF 2,3
- 5Y JIF 2,7
- JCI —
Subject classification
Categories (SJR)
Areas
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2021 | Q2 | — | 0,642 | — | — | — | — | 63 |
| 2020 | Q2 | — | 0,98 | — | — | — | — | 63 |
| 2019 | Q2 | — | 0,904 | — | — | — | — | 63 |
| 2018 | — | Q3 | — | 2,3 | 2,7 | — | — | — |
| 2017 | Q1 | Q3 | 1,104 | 2,6 | 2,9 | — | — | 63 |
| 2016 | Q1 | Q2 | 1,157 | 3,3 | 3 | — | — | 63 |
| 2015 | Q1 | Q2 | 1,072 | 2,7 | 2,8 | — | — | 63 |
| 2014 | Q1 | Q3 | 1,06 | 2,6 | 2,8 | — | — | 63 |
| 2013 | Q1 | Q2 | 1,168 | 2,7 | 2,5 | — | — | 63 |
| 2012 | Q1 | Q2 | 0,947 | 2,8 | 2,3 | — | — | 63 |
| 2011 | Q2 | Q2 | 0,708 | 2,1 | 1,5 | — | — | 63 |
| 2010 | Q2 | Q4 | 0,495 | 0,9 | 0,9 | — | — | 63 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 40/65 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 34/65 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 24/63 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 31/63 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/60 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 31/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 23/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 34/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 57/68 |